Yactum 250mg/125mg Injection
Marketer
Forgo Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Yactum 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a physician's guidance. Complete the prescribed regimen, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications, including over-the-counter drugs, to your doctor before initiating treatment. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration facilitate recovery. Follow-up laboratory tests may be necessary to monitor therapeutic response.
Uses of Yactum 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Yactum 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Yactum 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Yactum 250mg/125mg Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
How Yactum 250mg/125mg Injection works:
Yactum Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a resistance modifier. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Yactum 250mg/125mg Injection's concurrent use with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Yactum (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
The administration of Yactum 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Yactum 250mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Yactum 250mg/125mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Yactum 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Yactum 250mg/125mg Injection are generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Yactum 250mg/125mg Injection :
Omit a Yactum 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Yactum 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently